Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04653324 · ClinicalTrials.gov registry record

A Registry for the Food Allergy Community

A clinical trial of Eosinophilic Esophagitis and Food Hypersensitivity, sponsored by Food Allergy Research & Education.

Recruiting
Registry status
23,000
Enrollment target
1
Study location

NCT04653324 is a study of Eosinophilic Esophagitis and Food Hypersensitivity that is actively recruiting participants, run by Food Allergy Research & Education. The registered enrollment target is 23,000 participants, above the 341-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (6645% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04653324, a study of Eosinophilic Esophagitis and Food Hypersensitivity, is actively recruiting participants, sponsored by Food Allergy Research & Education.

RECRUITING
Registry status
23,000 participants
Enrollment target
1
Study location

Study Summary

The FARE Patient Registry will serve as a prospective, observational food allergy reporting system that stores detailed health and other basic information about patients' real-world experiences with food allergies, to encourage open sharing of de-identified data and participation in clinical trials. The FARE Patient Registry intends to make and support scientific discoveries by enabling the food allergy community to participate directly in research.

Study Locations (1)

Virginia

  • Food Allergy Research & Education - McLean

Trial Details

FieldValue
Enrollment Target 23,000 participants
Start Date 2017-08-24
Est. Completion 2027-08

What the Registry Record Tells You About NCT04653324

The ClinicalTrials.gov registry entry for NCT04653324 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 23,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 341-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (6645% higher). The listed sponsor is Food Allergy Research & Education, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 0 interventions.

NCT04653324 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT04653324 about?

NCT04653324 is a clinical study titled "A Registry for the Food Allergy Community". The FARE Patient Registry will serve as a prospective, observational food allergy reporting system that stores detailed health and other basic information about patients' real-world experiences with food allergies, to encourage open sharing of de-identified data and participation in clinical trials....

What is the current status of trial NCT04653324?

This trial is currently recruiting. The enrollment target is 23,000 participants. The study started on 2017-08-24. Estimated completion is 2027-08.

What conditions does trial NCT04653324 study?

This clinical trial studies the following conditions: Eosinophilic Esophagitis, Food Hypersensitivity, Food Allergy in Infants, Anaphylaxis, Food Sensitivity.

Who is sponsoring clinical trial NCT04653324?

This trial is sponsored by Food Allergy Research & Education, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04653324 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Eosinophilic Esophagitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.